TINAZZI MARTINI GOBBO, Stefano
 Distribuzione geografica
Continente #
EU - Europa 7.695
NA - Nord America 6.920
AS - Asia 4.507
SA - Sud America 539
Continente sconosciuto - Info sul continente non disponibili 176
AF - Africa 130
OC - Oceania 11
Totale 19.978
Nazione #
US - Stati Uniti d'America 6.778
RU - Federazione Russa 2.429
SG - Singapore 1.732
GB - Regno Unito 1.699
IT - Italia 1.516
CN - Cina 1.445
SE - Svezia 450
BR - Brasile 428
HK - Hong Kong 401
DE - Germania 359
VN - Vietnam 349
FR - Francia 337
IE - Irlanda 277
FI - Finlandia 262
KR - Corea 138
BD - Bangladesh 106
UA - Ucraina 86
NL - Olanda 80
CA - Canada 77
IN - India 64
JP - Giappone 61
TR - Turchia 55
AR - Argentina 39
PL - Polonia 37
NG - Nigeria 35
MX - Messico 34
ES - Italia 32
BE - Belgio 30
ZA - Sudafrica 29
ID - Indonesia 26
IQ - Iraq 21
AT - Austria 18
CO - Colombia 15
EC - Ecuador 15
IR - Iran 14
CL - Cile 12
TG - Togo 12
CZ - Repubblica Ceca 11
LT - Lituania 11
PK - Pakistan 11
BJ - Benin 10
SA - Arabia Saudita 10
VE - Venezuela 10
AU - Australia 9
DZ - Algeria 9
PT - Portogallo 9
PY - Paraguay 9
KE - Kenya 8
UZ - Uzbekistan 8
IL - Israele 7
LV - Lettonia 7
MA - Marocco 7
PH - Filippine 7
RS - Serbia 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
CH - Svizzera 6
JO - Giordania 6
MY - Malesia 6
RO - Romania 6
DO - Repubblica Dominicana 5
AM - Armenia 4
CR - Costa Rica 4
ET - Etiopia 4
EU - Europa 4
JM - Giamaica 4
KZ - Kazakistan 4
MT - Malta 4
PE - Perù 4
TN - Tunisia 4
UY - Uruguay 4
BB - Barbados 3
BO - Bolivia 3
CI - Costa d'Avorio 3
CM - Camerun 3
HN - Honduras 3
IM - Isola di Man 3
KG - Kirghizistan 3
LB - Libano 3
NP - Nepal 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
AL - Albania 2
DK - Danimarca 2
DM - Dominica 2
EG - Egitto 2
GE - Georgia 2
GR - Grecia 2
HR - Croazia 2
MD - Moldavia 2
NO - Norvegia 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SN - Senegal 2
AI - Anguilla 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
GN - Guinea 1
Totale 19.794
Città #
Southend 1.473
Singapore 951
Moscow 848
Ashburn 738
San Jose 648
Chandler 647
Jacksonville 622
Dallas 503
Hong Kong 397
Ann Arbor 327
Council Bluffs 309
Woodbridge 300
Dublin 275
Verona 270
Beijing 260
The Dalles 190
Los Angeles 153
New York 136
Houston 117
Jinan 111
Ho Chi Minh City 105
Wilmington 105
Lawrence 100
Princeton 100
Nanjing 96
Milan 94
Hanoi 88
Rome 88
Munich 86
Shenyang 76
Helsinki 73
Buffalo 63
São Paulo 59
Hebei 53
Tokyo 52
Tianjin 50
Santa Clara 48
Bologna 47
Zhengzhou 41
Lancaster 40
Orem 40
Columbus 39
Taizhou 37
Guangzhou 36
London 36
Sindelfingen 36
Abuja 34
Changsha 33
Dearborn 33
Haikou 33
Montreal 31
Ningbo 31
Redondo Beach 31
Taiyuan 29
Turku 29
Brussels 28
Warsaw 27
Denver 25
Frankfurt am Main 25
San Francisco 24
Amsterdam 23
Chennai 23
Phoenix 23
Toronto 23
Seattle 22
Seoul 21
Stockholm 20
Nanchang 19
Boardman 17
Chicago 17
Mexico City 17
Rio de Janeiro 17
Atlanta 16
Brooklyn 16
Johannesburg 16
Manchester 16
Palermo 16
Redwood City 16
Washington 16
Jiaxing 15
Bari 14
Madrid 14
Norwalk 14
Nuremberg 14
Redmond 14
Da Nang 13
Hangzhou 13
Naples 13
Paris 13
Turin 13
City of London 12
Falls Church 12
Haiphong 12
Vienna 12
Boston 11
Lanzhou 11
Lomé 11
Baghdad 10
Biên Hòa 10
Cotonou 10
Totale 11.991
Nome #
I tumori ibridi nell'oncocitosi renale sono l'anello di congiunzione tra oncocitoma renale e il carcinoma renale di tipo cromofobo? 680
CLEAR CELL-PAPILLARY RENAL CELL CARCINOMA 414
Instabilità dei microsatelliti nei carcinomi duttali e nei tumori endocrini del pancreas 379
Schwannoma del rene 263
Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors? 261
Analisi citogenetica in metafase ed interfase nel carcinoma renale cromofobo e nell'onocitoma del rene 260
Breast cancer with both assessment of Her2/Neu overexpression and gene amplification:clinical impact in selecting patients for drug treatment 258
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 253
True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs 248
iPathology cockpit diagnostic station: validation according to College of American Pathologists Pathology and Laboratory Quality Center recommendation at the Hospital Trust and University of Verona 233
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 228
Carcinomi con traslocazioni coinvolgenti i geni della famiglia MiTF/TFE. 225
Carcinoma a cellule renali associato ad evidente proliferazione stromale leiomiomatosa 225
Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery? 219
Carcinoma a cellule renali di tipo papillare a cellule oncocitiche: studio clinico-patologico di 10 casi. 218
Chondroid syringoma with extensive ossification 218
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 214
Tumor thrombosis: a peculiar finding associated with pancreatic neuroendocrine neoplasms. A pictorial essay 212
CARCINOMI DELLA MAMMELLA POSITIVI ALL'IMMUNOESPRESSIONE PER HER-2: VALUTAZIONE CON METODICA FISH DEI CASI CON IMMUNOESPRESSIONE INTRATUMORALE ETEROGENEA 211
Utilità diagnostica della valutazione della ploidia con citometria a flusso nella diagnosi differenziale delle neoplasie a cellule renali 202
Correlation of MR features and histogram-derived parameters with aggressiveness and outcomes after resection in pancreatic ductal adenocarcinoma 202
Oncocytic papillary renal cell carcinoma: potential pitfall in small enucleation. 198
Carcinoma renale a cellule chiare papillare: una distinta entità istopatologica e genetica 197
ESGAR 2016 Book of Abstracts 196
Oncocytic Intraductal Papillary Mucinous Neoplasms of the Pancreas: Imaging and Histopathological Findings 195
Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas 194
[Diagnostic and prognostic markers in renal tumors] 193
Carcinomi della mammella con valutazione dello stato di Her-2 mediante immunoistochimica ed ibridazione in situ fluorescente: impatto clinico nella selezione dei pazienti per la terapia con Herceptin 192
Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage 192
Neuroendocrine Neoplasms 192
Histopathology and Long-Term Outcome of Kidneys Transplanted From Donors With Severe Acute Kidney Injury 191
Expression of GATA-3 among renal cell and urothelial neoplasms 186
Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinoma 184
Espressione di CD23 nelle neoplasie cutanee annessiali 184
Genotypic Intratumoral Heterogeneity in Breast Carcinoma with HER2/neu Amplification Evaluation According to ASCO/CAP Criteria 183
Classical lobular breast carcinoma consistently lacks topoisomerase-IIα gene amplification: implications for the tailored use of anthracycline-based chemotherapies 183
Diagnostic usefulness of fluorescent cytogenetics in differentiating chromophobe renal cell carcinoma from renal oncocytoma: a validation study combining metaphase and interphase analyses 182
Subepithelial Pelvic Hematoma (Antopol-Goldman Lesion) Simulating Renal Neoplasm: Report of a Case and Review of the Literature 182
Cathepsin K: A Novel Diagnostic and Predictive Biomarker for Renal Tumors 182
Carcinomi renali papillari con aree di cellule chiare 181
Her-2/neu evaluation in Sister Mary Joseph's nodule from breast carcinoma: a case report and review of the literature 179
L'ESPRESSIONE DI CITOCHERATINE E' IN ACCORDO CON LA DIFFERENZIAZIONE EPITELIALE DELLE NEOPLASIE RENALI HMB45 POSITIVE CON TRASLOCAZIONE T(6;11) 178
Intravoxel incoherent motion diffusion-weighted MR imaging of solid pancreatic masses: reliability and usefulness for characterization 178
Subepithelial haematoma of the renal pelvis (Antopol-Goldman lesion) 177
Cathepsin K expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney 176
Tumor seeding after percutaneous US-guided FNA of solid pancreatic neoplasms 176
Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma 175
Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions 175
Role of next-generation genomic sequencing in targeted agents repositioning for pancreaticoduodenal cancer patients 175
Expression pattern of claudins 5 and 7 distinguishes solid-pseudopapillary from pancreatoblastoma, acinar cell and endocrine tumors of the pancreas 174
Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma 174
Utilità diagnostica di CD13 e CD10 nelle neoplasie a cellule renali 173
t(6;11) renal cell carcinoma: a study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa/epithelioid angiomyolipoma 173
Molecular pathology of lymphangioleiomyomatosis and other perivascular epithelioid cell tumors 169
Utility of racemase and other immunomarkers in the detection of adenocarcinoma in prostatic tissue damaged by high intensity focused ultrasound therapy 167
La perdita del 9p è un fattore prognostico nei pazienti affetti da carcinoma a cellule chiare del rene 166
Proximal CD13 Versus Distal GATA-3 Expression in Renal Neoplasia According to WHO 2016 Classification 166
Cathepsin-k expression in pulmonary lymphangioleiomyomatosis 163
Pancreatic neuroendocrine neoplasms: MRI features and correlation with their histological grade 163
Histogram analysis of ADC maps: assessment of intra-tumoral heterogeneity and correlation with the biological behavior of pancreatic neuroendocrine neoplasms 163
Ultrasound-guided percutaneous fine-needle aspiration of solid pancreatic neoplasms: 10-year experience with more than 2,000 cases and a review of the literature 159
Serous Neoplasms 159
Patterns of 1p/19q chromosomal abnormalities among glial neoplasms 158
Magnetic resonance (MR) for mural nodule detection studying Intraductal papillary mucinous neoplasms (IPMN) of pancreas: Imaging-pathologic correlation 157
Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases 156
Clear-Cell Papillary Renal cell Carcinoma: a Distinct Histopathological and Molecular Genetic Entity 151
Significato prognostico della perdita del cromosoma 9P nei carcinomi renali a cellule chiare stratificati per UISS e SSIGN score 150
S100A1 ed S100 nella diagnosi differenziale delle neoplasie epiteliali del rene 150
Giant cell inflammatory reaction to hemostatic cellulose matrix mimicking renal cell carcinoma recurrence 148
Interphase Cytogenetic in Metastatic Chromophobe Renal Cell Carcinoma (RCC) 148
S-100A1 is a reliable marker in distinguishing nephrogenic adenoma from prostatic adenocarcinoma 146
Human aspartic protein napsin-A: immunoistochemical detection among renal cell neoplasms 146
Giant Brunner's gland adenoma 146
Parvalbumin immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney 144
Uncommon presentations of common pancreatic neoplasms: a pictorial essay 143
Immunohistochemical profile of common epithelial neoplasms arising in the kidney 142
Many facets of chromosome 3p cytogenetic findings in clear cell renal carcinoma: the need for agreement in assessment FISH analysis to avoid diagnostic errors 139
TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms 138
Update on the molecular pathogenesis of pancreatic tumors other than common ductal adenocarcinoma 138
Fluorescent cytogenetics of renal cell neoplasms 137
Neuroendocrine Neoplasm 135
Role of molecular markers in diagnosis and prognosis of renal cell carcinoma 134
Forensic value of soft tissue detachments from the hyoid bone in death due to strangulation asphyxia 134
Utility of tissue microarrays for assessment of diagnostic chromosomal abnormalities in chromophobe renal cell carcinoma 133
Utilità del tissue microarray nella valutazione delle anomalie cromosomiche del carcinoma renale di tipo cromofobo 132
iForensic, multicentric validation of digital whole slide images (WSI) in forensic histopathology setting according to the College of American Pathologists guidelines 131
Tumour thrombosis: an uncommon finding associated with pancreas tumours 130
TSC loss is a clonal event in eosinophilic solid and cystic renal cell carcinoma: a multiregional tumor sampling study 125
Artificial intelligence-based algorithms for the diagnosis of prostate cancer: A systematic review 123
Periorbital subcutaneous tumor-like lesion due to Dirofilaria repens 122
Tumour thrombosis: an uncommon finding associated with pancreatic tumours 122
Marcatori Diagnostici e Prognostici nei Tumori Renali 121
PROGNOSTIC ROLE OF CHROMOSOME 9P DELETION IN PATIENTS WITH CLEAR CELL RENAL CELL CARCINOMA 120
Pancreatic Neuroendocrine Neoplasms: Clinical Value of Diffusion-Weighted Imaging 119
Characterization of two transcriptomic subtypes of marker-null large cell carcinoma of the lung suggests different origin and potential new therapeutic perspectives 117
Clear-cell papillary renal cell carcinoma: a distinct histopathological and molecular genetic entity 116
TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder urothelial carcinoma 115
Hybrid Tumors, Oncocytomas and Chromophobe Renal Cell Carcinomas, , 2005 115
Atypical suicide by single incising cut to the throat without hesitation marks: Case report and review of the literature 114
Digital pathology world tour 112
Totale 18.075
Categoria #
all - tutte 64.465
article - articoli 41.060
book - libri 0
conference - conferenze 20.801
curatela - curatele 0
other - altro 852
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.752
Totale 128.930


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022877 0 281 12 96 56 50 14 46 25 24 94 179
2022/20231.972 129 219 188 303 194 454 36 126 194 34 50 45
2023/20241.054 44 82 95 114 115 144 58 73 30 47 186 66
2024/20252.655 136 146 148 438 119 98 107 133 356 202 271 501
2025/20268.166 533 391 553 1.386 2.035 557 699 442 673 487 173 237
2026/2027323 113 210 0 0 0 0 0 0 0 0 0 0
Totale 19.978